Sepsis-induced cholestasis

Hepatology

Volumn 45, Issue 1, 2007, Pages 230-241

  Chand, Nisha ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; INDINAVIR; MOLSIDOMINE; NITROFURANTOIN; PARACETAMOL; PENICILLIN G; PHENAZOPYRIDINE; PRIMAQUINE; QUININE; SULFONAMIDE; URSODEOXYCHOLIC ACID;

BACTEREMIA; BILIARY TRACT DISEASE; BILIRUBIN METABOLISM; CHOLESTASIS; CLINICAL FEATURE; GRAM NEGATIVE INFECTION; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LEPTOSPIROSIS; LIVER ABSCESS; LIVER TOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PORTAL VEIN INFECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; TYPHOID FEVER;

BILIRUBIN; CHOLESTASIS; HEMOLYSIS; HUMANS; LIVER; RISK FACTORS; SEPSIS;

EID: 33846426043     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21480     Document Type: Review

References (77)

1. Garvin IP. Remarks on pneumonia biliosa. S Med Surg 1837;1:536:544.
2. Whitehead MW, Hainsworth I, Kingham JG. The causej of obvious jaundice in South West Wales: perceptions versus reality. Gut 2001;48:409-413.
3. Hamilton JR, Sass-Kortsak A. Jaundice associated with severe bacterial infection in young infants. J Pediatr 1963;63:121-132.
4. Vermillion SE, Gregg JA, Baggenstoss AH, Bartholomew LG. Jaundice associated with bacteremia. Arch Intern Med 1964;124:611-618.
5. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 1991;19:165-181.
6. Moseley RH. Sepsis and cholestasis. Clin Liver Dis 1999;3:465-475.
7. Neale G, Caughey D, Mollin DL, Booth CC. Effects of intrahepatic and extrahepatic infection on liver function. Br Med J 1966;1:382-387.
8. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician 2004;69:299-304.
9. Roelofsen H, Van Der Veere C, Ottenhoff R, Schoemaker B, Jansen PL, Oude Elferink RP. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 1994;107:1075-1084.
10. Zucker SD, Storch J, Zeidel L, Gollan JL. Mechanism of the spontaneous transfer of unconjugated bilirubin between small unilamellar phosphatidylcholine vesicles. Biochemistry 1992;31:3184-3192.
11. Moseley R. Sepsis and cholestasis. Clin Liver Dis 2004;8:94.
12. Bolder U, Ton-Nu H-T, Schteingart C, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion. Gastroenterology 1997;112:214-215.
13. Jansen PL, Mulder GJ, Burchell B, Bock KW. New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease." Hepatology 1992;15:532-544.
14. Moseley RH. Sepsis-associated jaundice-comments. Hepatology 1996; 24:969-970.
15. Gerloff T, Steiger B, Hagenbuch B, Madon J, Landmann L, Roth J, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-10050.
16. Ng S, Rawston J. Urinary tract infections presenting with jaundice. Arch Dis Child 1971;46173-176.
17. Tugswell P, Williams O. Jaundice associated with lobar pneumonia. A clinical, laboratory, and histological study. Q J Med 1977;66:97-118.
18. Zimmerman H, Thomas L. The liver in pneumococcal pneumonia: observations in 94 cases on liver function and jaundice in pneumonia. J Lab Clin Med 1950;35:556-567.
19. Franson T, Hierholzer W, LaBrecque D. Frequency and characteristics of hyperbilirubinemia associated with bacteria. Rev Infect Dis 1985;7:1-9.
20. Zimmerman H. Jaundice due to bacterial infection. Gastroenterology 1979;77:362-374.
21. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med 2003;31(12 Suppl):S651-S657.
22. Berkowitz FE. Hemolysis and infection: categories and mechanisms of their interrelationship. Rev Infect Dis 1991;13:1151-1162.
23. Batge B, Filejski W, Kurowski V, Kluter H, Djonlagic H. Clostridial sepsis with massive intravascular hemolysis: rapid diagnosis and successful treatment. Intensive Care Med 1992;18:488-490.
24. Smith LD. Virulence factors of Clostridium perfringens. Rev Infect Dis 1979;1:254-262.
25. Rosenthal D. Hematologic Manifestations of Infectious Disease. Hematology Basic Principles and Practice. Churchill Livingstone, Inc, 1995: 2162.
26. Beutler E. G6PD deficiency. Blood 1994;84:3613-3636.
27. Dhaliwal G, Cornett PA, Tierney LM, Jr. Hemolytic anemia. Am Fam Physician 2004;69:2599-2606.
28. Shander A. Anemia in the critically ill. Crit Care Clin 2004;20:159-178.
29. Sokol R, Hewitt S. Autoimmune hemolysis: a critical review. Crit Rev Oncol Hematol 1985;4:125-154.
30. Lindsay K. Nonviral infections of the liver. In: Gitnick G, ed. Principles and Practice of Gastroenterology and Hepatology. Norwalk, CT: Appleton and Lange, 1994.
31. Dwain L. Thiele. Hepatic dysfunction during systemic infection. In: Sleisenger and Fordtran's Gastrointesrinal and Liver Disease. Philadelphia, PA: W.B. Saunders Company, 1998.
32. Garratty G. Review: drug-induced immune hemolytic anemia-the last decade. Immunohematol 2004;20:138-146.
33. Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Transfusion 2004;44:1033-1040.
34. Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005;42:137-144.
35. Trauner M, et al. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-1227.
36. Hutchins G, Gollan J. Recent developments in the pathophysiology of cholestasis. Clin Liver Dis 2004;8:1-26.
37. Beeson P, Brannon E, Warren J. Observations on the sites of removal of bacteria from the blood in patients with bacterial endocarditis. J Exp Med 1945;81:9-23.
38. Hinshaw L, Reins D, Hill R. Response of isolated liver to endotoxin. Can J Physiol Pharmacol 1966;44:529-541.
39. Szabo G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002;6:1045.
40. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PL, Elferink RP. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995;269:G427-G434.
41. Nolan J. Intestinal endotoxins as mediators of hepatic injury-an idea whose time has come again. Hepatology 1989;10:887-891.
42. Ballas M, Giron J. Reversible hepatitis with Hemophilus influenzae sepsis. N Y State J Med 1982;1063-1065.
43. Boekhorst T, Urlus M, Doesburg W, Yap S, Goris R. Etiologic factors of jaundice in severely ill patients. J Hepatol 1988;7:111-117.
44. Sherlock S. The liver in circulatory failure, diseases of the liver. In: Schiff L, Schiff ER, eds. Diseases of the Liver. Philadelphia, PA: J.B. Lippincott Company, 1993.
45. Ledgerwood A. Hepatobiliary complications of sepsis. Heart Lung 1976; 5:621-623.
46. Nadler E, Dickinson E, Beer-Stolz D, Alber SM, Watkins SC, Pratt DW, et al. Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge. Am J Physiol Gastrointest Liver Physiol 2001;281:G173-G181.
47. Wang P, Ba ZF, Chaudry IH. Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis. Shock 1995;3: 21-26.
48. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996;270(5 Pt 2):R927-R938.
49. Whiting J, Green R, Rosenbluth A, Gollan J. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. HEPATOLOGY 1995;22:1273-1278.
50. Green R, Beier D, Gollan J. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996;111:193-198.
51. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997;112:214-225.
52. Moseley RH, Wang W, Takeda H, Lown K, Shick L, Ananthanarayanan M, et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996;271:G137-G146.
53. Utili R, Abernathy C, Zimmerman H. Inhibition of Na+, K+-adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis. J Infec Dis 1997;136:583-587.
54. Salgia R, Becker J, Sayeed M. Altered membrane fluidity in rat hepatocytes during endotoxic shock. Mol Cell Biochem 1993;121:143-148.
55. Brandorg L, Goldman I. Bacterial and miscellaneous infections of the liver. In: Hepatology, A Textbook of the Liver. Philadelphia, PA: W.B. Saunders, 1990:1086-1098.
56. Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, Sanz L, Carreno G, Junco A, et al. Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg 2001;181:177-186.
57. Wong TY, Chiu SI, So MK, Tsang MK, Lai ST, Tse KK, et al. Septic metastatic endophthalmitis complicating Klebsiella pneumoniae liver abscess in a non-diabetic Chinese man. Hong Kong Med J 2001;7:303-306.
58. Srivastava ED, Mayberry JF. Pyogenic liver abscess: a review of aetiology, diagnosis and intervention. Dig Dis 1990;8:287-293.
59. Alvarez Perez JA, Baldonedo Cernuda RF, Gonzalez Gonzalez JJ, Sanz AL, Carreno VG, Garcia BI, et al. [Pyogenic liver abscesses of cryptogenic origin]. An Med Interna 2001;18:473-478.
60. Bernstein J, Brown AK. Sepsis and jaundice in early infancy. Pediatrics 1962;29:873-882.
61. Terebelo H, McCue R, Lenneville M. Implication of plasma free hemoglobin in massive clostridial hemolysis. JAMA 1982;248:2028-2029.
62. Becker RC, Giuliani M, Savage RA, Weick JK. Massive hemolysis in Clostridium perfringens infections. J Surg Oncol 1987;35:13-18.
63. Barrett JP, Whiteside JL, Boardman LA. Fatal clostridial sepsis after spontaneous abortion. Obstet Gynecol 2002;99(5 Pt 2):899-901.
64. Chen YM, Lee HC, Chang CM, Chuang YC, Ko WC. Clostridium bacteremia: emphasis on the poor prognosis in cirrhotic patients. J Microbiol Immunol Infect 2001;34:113-118.
65. Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002;23:469-478.
66. De Brito T, Bohm GM, Yasuda PH. Vascular damage in acute experimental leptospirosis of the guinea-pig. J Pathol 1979;128:177-182.
67. Ramachandran S, Godfrey JJ, Perera MV. Typhoid hepatitis. JAMA 1974; 230:236-240.
68. Pramoolsinsap C, Viranuvatti V. Salmonella hepatitis. J Gastroenterol Hepatol 1998;13:745-750.
69. Pirovino M, Meister F, Rubli E, Karlaganis G. Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection. Gastroenterology 1989;96:1589-1595.
70. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 1991;19:165-181.
71. Duerksen DR, Van Aerde JE, Gramlich L, Meddings JB, Chan G, Thomson AB, et al. Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets. Gastroenterology 1996;111:1111-1117.
72. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders.' J Hepatol 2001;35: 134-146.
73. Yang S, Koo DJ, Chaudry IH, Wang P. Glycine attenuates hepatocellular depression during early sepsis and reduces sepsis-induced mortality. Crit Care Med 2001;29:1201-1206.
74. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240:419-424.
75. Kim YM, Kim TH, Chung HT, Talanian RV, Yin XM, Billiar TR. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. HEPATOLOGY 2000;32:770-778.
76. Brown KM, Brems JJ, Moazzam FN, Hartman GG, Gamelli RL, Ding JW. The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia. J Am Coll Surg 2003;197:261-269.
77. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994;266:H1746-H1754.